| Pharmaceutical active ingredients: |
| Carbetapentane Citrate |
| Available forms, composition and doses of Toclase Toux Seche: |
| Solution; Oral; Carbetapentane Citrate 2.13 mg / ml |
| Toclase Toux Seche medical category: |
| Human:Cough and cold preparations |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| R05DB05 - Pentoxyverine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| UCB PharmaPierre Fabre |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Pectosan Toux Seche | Carbetapentane Citrate | Cooperation Pharmaceutique Francaise |
| Pectosan Toux Seche Adultes | Carbetapentane Citrate | Cooperation Pharmaceutique Francaise |
| Pectosan Toux Seche Enfantes | Carbetapentane Citrate | Cooperation Pharmaceutique Francaise |
| Sirop Pectoral Vicks | Carbetapentane Citrate | Procter & Gamble |
| Toclase | Carbetapentane Citrate | UCB Pharma; Vedim Pharma; Zuellig Pharma |
| Tussa-Tablinen | Carbetapentane Citrate | Lichtenstein Pharmazeutica |
| Vicks Pectoral | Carbetapentane Citrate | Procter & Gamble |
| Carbin | Carbetapentane Citrate; Carbetapentane Hydrochloride | Rowe-Fleming Laboratorios |
| Tuclase | Carbetapentane Citrate; Carbetapentane Hydrochloride | UCB Pharma |
| Vicks Acta Plus | Carbetapentane Citrate; Cetylpyridinium Chloride; Chloroform; Guaifenesin; Sodium Citrate | Procter & Gamble |